Accessibility Menu
Carlsmed Stock Quote

Carlsmed (NASDAQ: CARL)

$13.71
(-0.7%)
-0.10
Price as of December 26, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$13.71
Daily Change
(-0.7%) $0.10
Day's Range
$13.17 - $13.94
Previous Close
$13.71
Open
$13.80
Beta
1.09
Volume
118,521
Average Volume
71,978
Market Cap
$365M
Market Cap / Employee
$13.71M
52wk Range
$11.55 - $17.19
Revenue
N/A
Gross Margin
0.75%
Dividend Yield
N/A
EPS
-$1.00
CAPs Rating
N/A
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Carlsmed Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
CARLN/AN/AN/A-5%
S&P+14.78%+87.14%+13.33%+9%
Advertisement

Carlsmed Company Info

Carlsmed, Inc. engages in the development of AI based technology solutions to the medical industry. Its solutions are utilized as an information database for surgeons using traditional surgical techniques. The company was founded by Mike Cordonnier and Niall Casey and is headquartered in Carlsbad, CA.

News & Analysis

No results found

No news articles found for Carlsmed.

Financial Health

General

Q3 2025YOY Change
Revenue$13.07M98.4%
Gross Profit$9.93M106.9%
Gross Margin75.93%3.1%
Market Cap$355.92M0.0%
Market Cap / Employee$3.56M0.0%
Employees1000.0%
Net Income-$8,526.00K-9.1%
EBITDA-$8,953.00K0.0%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q3 2025YOY Change
Net Cash$115.47M0.0%
Accounts Receivable$11.30M0.0%
Inventory1.30.0%

Liabilities

Q3 2025YOY Change
Long Term Debt$16.95M0.0%
Short Term Debt$661.00K0.0%

Ratios

Q4 2024YOY Change
Return On Assets-73.68%0.0%
Return On Invested Capital-174.29%0.0%

Cash Flow

Q3 2025YOY Change
Free Cash Flow-$8,618.00K0.0%
Operating Free Cash Flow-$8,459.00K0.0%

Valuation

MetricQ3 2025YoY Change
Price to Book-4.14-
Price to Sales7.95-
Price to Tangible Book Value-4.14-
Enterprise Value to EBITDA-28.83-
Return on Equity-212.4%-
Total Debt$17.18M$17.08M$17.71M$17.61M54.69%

No results found

No podcast episodes available.

No results found

No transcripts available.

Advertisement

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.